Botulinum Toxin Type A Treatment for Contouring of the Lower Face
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 29 (5) , 477-483
Abstract
Background. Since type A botulinum toxin was first reported for the treatment of masseter muscle hypertrophy in 1994, there have been few reports about cosmetic indications for contouring procedures...Keywords
This publication has 9 references indexed in Scilit:
- A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurementBritish Journal of Plastic Surgery, 2001
- Type A Botulinum Toxin for the Treatment of Hypertrophy of the Masseter and Temporal Muscles: An Alternative TreatmentPlastic and Reconstructive Surgery, 2001
- Botulinum Toxin A for the Treatment of Facial Hyperkinetic Wrinkle Lines in KoreansPlastic and Reconstructive Surgery, 2000
- Treatment of unilateral masseteric hypertrophy with botulinum toxin: Case reportJournal of Oral and Maxillofacial Surgery, 1999
- Mandibular Contouring Surgery by Angular Contouring Combined with Genioplasty in OrientalsPlastic and Reconstructive Surgery, 1998
- Dose‐response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type ANeurology, 1996
- The medical management of masseteric hypertrophy with botulinum toxin type ABritish Journal of Oral and Maxillofacial Surgery, 1994
- Botulinum toxin treatment of bilateral masseteric hypertrophyBritish Journal of Oral and Maxillofacial Surgery, 1994
- ‘Ping-pong’ gazeNeuro-Ophthalmology, 1992